Corcept Therapeutics Balance Sheet
NASDAQ: CORTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Corcept Therapeutics financial position
At the end of fiscal 2025, Corcept Therapeutics reported total assets of $836.7 million, down 0.5% from a year earlier against total liabilities of $188.8 million. Shareholders' equity stood at $647.8 million, or 77.4% of assets. The company held $120.5 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 2.92, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Corcept Therapeutics balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 120.50M | 127.67M | 135.55M | 66.33M | 77.62M | 76.19M | 31.27M | 41.63M | 31.06M | 51.54M |
| Short-Term Investments | 251.66M | 255.67M | 232.67M | 365.34M | 145.92M | 364.51M | 244.69M | 165.13M | 57.68M | 0 |
| Receivables | 59.79M | 53.98M | 41.12M | 31.06M | 27.63M | 26.20M | 19.93M | 17.59M | 15.30M | 9.86M |
| Inventory | 12.87M | 12.41M | 7.73M | 6.10M | 4.99M | 4.91M | 5.42M | 4.73M | 4.58M | 2.33M |
| Total Current Assets | 485.46M | 471.60M | 458.64M | 499.25M | 266.46M | 478.50M | 307.36M | 236.82M | 124.19M | 65.69M |
| Property, Plant & Equipment | 1.89M | 2.69M | 195.00K | 633.00K | 1.00M | 1.68M | 1.05M | 655.00K | 518.00K | 205.00K |
| Long-Term Investments | 160.27M | 219.83M | 57.18M | 4.95M | 112.28M | 36.20M | 39.35M | 0 | 15.28M | 0 |
| Total Assets | 836.65M | 840.55M | 621.52M | 583.43M | 423.76M | 571.73M | 412.31M | 311.69M | 220.54M | 68.75M |
| Accounts Payable | 40.44M | 15.38M | 17.40M | 11.98M | 6.91M | 10.55M | 7.54M | 8.27M | 8.58M | 2.29M |
| Short-Term Debt | — | — | — | — | — | — | — | — | 0 | 14.66M |
| Total Current Liabilities | 166.09M | 140.77M | 104.50M | 72.49M | 47.54M | 47.49M | 38.84M | 35.57M | 29.57M | 27.37M |
| Long-Term Debt | — | — | — | — | — | — | — | — | 0 | 0 |
| Total Liabilities | 188.85M | 160.96M | 114.81M | 81.59M | 47.95M | 48.39M | 41.13M | 35.81M | 29.57M | 27.37M |
| Shareholders' Equity | 647.80M | 679.59M | 506.70M | 501.84M | 375.81M | 523.34M | 371.18M | 275.88M | 190.97M | 41.38M |
| Retained Earnings | 643.39M | 543.74M | 402.53M | 296.39M | 194.97M | 82.46M | -23.55M | -117.74M | -193.15M | -322.27M |
| Total Debt | — | — | — | — | — | — | — | — | 0 | 14.66M |
| Net Cash (Debt) | 372.15M | 383.33M | 368.22M | 431.67M | 223.53M | 440.70M | 275.96M | 206.76M | 88.74M | 36.87M |
| Shares Outstanding | 105.97M | 105.11M | 103.41M | 107.83M | 105.94M | 116.73M | 114.55M | 115.03M | 114.72M | 112.71M |
This table shows 10 annual periods of Corcept Therapeutics's balance sheet, from FY 2025 back to FY 2016, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow CORT's reporting calendar. What is a balance sheet?